Argyle
Payments companies reported to CMS as associated with Argyle. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Argyle, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Argyle
These are the largest totals companies reported as associated with Argyle. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Satyaki Banerjee | Albuquerque, NM | Nephrology (Internal Medicine) | $97,504.04 |
| Micah Chan | Fitchburg, WI | Nephrology (Internal Medicine) | $31,354.86 |
| Wissam Saliba | Wichita, KS | Internal Medicine | $12,984.22 |
| David Bjerken | Little River, SC | Surgery | $5,441.22 |
| Robert Lee | Grosse Pointe Shores, MI | Vascular Surgery | $4,750.00 |
| Dirk Hentschel | Boston, MA | Nephrology (Internal Medicine) | $2,560.01 |
| Udaya Chintalapudi | Loganville, GA | Vascular & Interventional Radiology | $1,594.72 |
| Drew Heiple | Russellville, AR | Nephrology (Internal Medicine) | $1,585.36 |
| Wei Li | Syracuse, NY | Vascular Surgery | $1,545.11 |
| Gurmukteshwar Singh | Saint Paul, MN | Nephrology (Internal Medicine) | $1,526.84 |
Prescribed Argyle?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.